SENSEX holds over 300-point lead, NIFTY50 firm above 25,250; Redington, Tata Communications, Natco Pharma among buzzing stocks
Natco Pharma shares rose as much as 6% to hit an intraday high of ₹863 following an update the company shared last evening. In its press release on October 9, the company said, with reference to the earlier update on April 8, 2025, the Ld. Single Judge of the Delhi High Court had, through an order dated 24.03.2025, denied Roche’s plea for an injunction against the company for the drug.
Natco Pharma shares rose as much as 6% to hit an intraday high of ₹863 following an update the company shared last evening. In its press release on October 9, the company said, with reference to the earlier update on April 8, 2025, the Ld. Single Judge of the Delhi High Court had, through an order dated 24.03.2025, denied Roche’s plea for an injunction against the company for the drug.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
